Moreover, another emergent area involves the role of miRNA regulation of ER subtypes and implications towards metastasis [62], which may translate to a new strategy for assessing diagnosis, treatment and prognosis of patients with ER-positive breast cancer and its association with metastasis. This evidence concerns the gene ESR1 and breast carcinoma.